Target intelligence / Profile preview

Penicillin-binding protein 1B (PBP1B) (PBP1B)

Target
PBP1B
Molecular classification
Enzyme, Penicillin-binding protein, Glycosyltransferase, Transpeptidase
01

Overview

Penicillin-binding protein 1B (PBP1B) is a critical bifunctional enzyme in Salmonella enterica responsible for the synthesis and maintenance of the bacterial peptidoglycan cell wall (Uddin et al., 2016). Encoded by the mrcB gene, PBP1B exhibits both transglycosylase activity, which polymerizes glycan chains, and transpeptidase activity, which cross-links these chains to provide structural integrity (Sun et al., 2014). While PBP1B is partially redundant with PBP1A, it is particularly important for Salmonella survival under environmental stressors such as high osmotic pressure and exposure to bile in the host's gallbladder (Garcia-del Portillo et al., 2020). As a primary target for beta-lactam antibiotics, including cephalosporins and penicillins, PBP1B's inhibition leads to the loss of cell wall stability and subsequent bacterial lysis (El-Fateh et al., 2024). However, the therapeutic efficacy of targeting PBP1B is increasingly challenged by the rise of multidrug-resistant (MDR) strains and the pathogen's ability to express alternative, low-affinity PBPs in intracellular niches (Garcia-del Portillo et al., 2020). Understanding the role of PBP1B in Salmonella pathogenesis is essential for developing next-generation antimicrobials and overcoming antibiotic resistance.

Other names
PBP1bmrcBPeptidoglycan glycosyltransferase/transpeptidase PBP1b
02

Mechanism of action

Inhibition of peptidoglycan transpeptidation by covalent binding to the active site serine residue, leading to cell wall destabilization and bacterial lysis.

03

Biological functions

Cell cycleCell deathCell wall biogenesisPeptidoglycan synthesisOsmotic stress responseBile resistance
04

Disease associations

InfectionSalmonellosisTyphoid fever
05

Safety considerations

Antibiotic resistanceMultidrug resistance (MDR)Intracellular persistenceGut microbiome disruption
06

Interacting drugs

Cefotaxime

5 more in the full profile.

07

Biomarkers

mrcB gene presencemrcB mutationsMinimum Inhibitory Concentration (MIC)

Beyond the preview

Go deeper on Penicillin-binding protein 1B (PBP1B) (PBP1B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Penicillin-binding protein 1B (PBP1B) (PBP1B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call